Penetration of Trypanosoma cruzi into mammalian cells depends on the activation of the parasites protein tyrosine kinase and on the increase in cytosolic Ca 2+ concentration. We used metacyclic trypomastigotes, the T. cruzi developmental forms that initiate infection in mammalian hosts, to investigate the association of these two events and to identify the various components of the parasite signal transduction pathway involved in host cell invasion. We have found that i) both the protein tyrosine kinase activation, as measured by phosphorylation of a 175-kDa protein (p175), and Ca 2+ mobilization were induced in the metacyclic forms by the HeLa cell extract but not by the extract of T. cruzi-resistant K562 cells; ii) treatment of parasites with the tyrosine kinase inhibitor genistein blocked both p175 phosphorylation and the increase in cytosolic Ca 2+ concentration; iii) the recombinant protein J18, which contains the full-length sequence of gp82, a metacyclic stage surface glycoprotein involved in target cell invasion, interfered with tyrosine kinase and Ca 2+ responses, whereas the monoclonal antibody 3F6 directed at gp82 induced parasite p175 phosphorylation and Ca 2+ mobilization; iv) treatment of metacyclic forms with phospholipase C inhibitor U73122 blocked Ca 2+ signaling and impaired the ability of the parasites to enter HeLa cells, and v) drugs such as heparin, a competitive IP 3 -receptor blocker, caffeine, which affects Ca 2+ release from IP 3 -sensitive stores, in addition to thapsigargin, which depletes intracellular Ca 2+ compartments and lithium ion, reduced the parasite infectivity. Taken together, these data suggest that protein tyrosine kinase, phospholipase C and IP 3 are involved in the signaling cascade that is initiated on the parasite cell surface by gp82 and leads to Ca 2+ mobilization required for target cell invasion.